Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2002

View Archived Issues

Boehringer Ingelheim and Genetronics sign gene therapy research agreement

Serono and Pfizer to copromote Rebif in the U.S.

Phase III patient enrollment complete for histrelin implant

Cell-based gene therapy research collaboration announced

Dyax acquires exclusive rights to a newly discovered prostate cancer target

Another major launch for Alcon's prostaglandin analogue for glaucoma

Russian researchers investigate profile of himantane, a potential new agent for Parkinson's disease

MetaPhore's lead SOD mimetics effective in animal models of pain and asthma

Antiplatelet/antithrombotic efficacy demonstrated for P2Y12 receptor antagonists

Ligands for EAATs identified in series of 5-methylglutamate analogues

Positive effects on aggressive behavior and learning reported for NVP-SRA-880

Desired profile confirmed for humanized PRO-140

Novel factor Xa inhibitor and oral prodrug presented at IUPHAR 2002 by Kissei

Novel FTase inhibitors in early development at Janssen

Vertex presents new caspase inhibitors for use in cancer, etc.

New p38alpha kinase inhibitors emerge from Scios R&D

Pfizer presents prostaglandin EP4 agonists for bone disorders

Synthesis, biological evaluation and use of NK1 antagonists reported by Roche

Estrogen receptor modulators with wide therapeutic application designed by Merck team

UCB claims novel GABA-A antagonists with antiepileptic activity

Clinical data support once-daily emtricitabine for HIV infection

Chiron licenses hepatitis C targets to Abbott

MedImmune receives FluMist complete response letter

Amrad discontinues development of AM-365

Enzon to reacquire Oncaspar rights from Aventis

Actimid shows antitumor activity in multiple myeloma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...